B cells have a key role in the regulation of immunity. Using gene expression studies of activated B cells, Shen et al. identified interleukin 35 (IL-35) as a new mediator of B cell-mediated immune regulation. Mice with B cells that did not express IL-35 were unable to recover from experimental autoimmune encephalomyelitis, and had improved resistance to infection with Salmonella enterica, which was mediated in part by an increased function of B cells as antigen-presenting cells. So IL-35 could be a putative new target for modulating immune function.